Official Fees: Article 64 of DE 490 and the B/.300 under Resolución 003

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Official fees (tasas) in the Panamanian device sector are consolidated in Article 64 of Decreto Ejecutivo N° 490, and only one credential can be priced item by item from the official text: the operating licence. The schedule sets manufacturer B/.350.00, conditioner B/.225.00, distributor B/.200.00, retailer B/.150.00, warehouse B/.150.00 and licence update B/.25.00. The technical standards certificate (CCT) is expressly free of charge under the third paragraph of Article 21. Per-category registration carries separate pricing: Article Décimo Sexto of Resolución N° 003 de 2024 sets the condom registration fee at B/.300.00, payable to the finance department of the Ministry of Health.

  • Six licence prices — five establishment categories plus a single update fee, all fixed in one article of the decree.
  • No sanitary registration line — the Article 64 schedule contains no fee for device sanitary registration, which is consistent with the moratorium position.
  • CCT at no cost — the product-side certificate carries no fee, but it does not follow that product access is free of cost overall.
  • Separate pricing for specific procedures — the condom registration fee of B/.300.00 is set by resolution rather than by the decree.
  • Two payees — licence fees are paid at DNDM with the application, while the per-category registration fee is paid to the Ministry of Health finance department.
  • Fees can be revised — Article 26 of Ley N° 90 provides for updating by executive decree, so the published figures are a starting point rather than a permanent schedule.

2. Legal basis

Article 64 of DE 490 of 4 October 2019 contains the licence schedule and the payment rule. The third paragraph of Article 21 states that the CCT carries no cost. Resolución N° 003 of 15 February 2024 prices a specific registration procedure. Article 26 of Ley N° 90 of 26 December 2017 supplies the mechanism by which the whole schedule may be updated.

Decreto Ejecutivo N° 490 (4 October 2019)Article 64Licencia de Operación: Fabricante B/.350.00; Acondicionador B/.225.00; Distribuidor B/.200.00; Minorista B/.150.00; Almacén B/.150.00; Actualización de la Licencia de Operación B/.25.00
Decreto Ejecutivo N° 490Article 64, introductory textFees must be paid at DNDM on submission of the corresponding application
Decreto Ejecutivo N° 490Article 21, third paragraph, final sentenceThe CCT no tendrá costo (carries no charge)
Resolución N° 003 (15 February 2024)Article Décimo SextoTrámite de Inscripción de Preservativos (Condones): 300.00, payable to the Ministry of Health finance department on submission of the application
Ley N° 90 (26 December 2017)Article 26Fees for operating licences, free sale certificates, GMP, storage and distribution certificates and sanitary registrations are set by the health authority and DNDM and updated by executive decree

3. Expert insights

Insight one: the fee schedule contains no item for device sanitary registration, which matches the moratorium. The table in Article 64 lists six prices, all connected with the operating licence. Read as evidence, the absence confirms that device sanitary registration has not become a routine chargeable procedure within the DE 490 system. Figures circulating in industry material, such as a registration fee somewhere between fifty and five thousand dollars, cannot be matched to Article 64 or to Resolución N° 003 and should not be relied on in a quotation. Where a client asks for a budget line labelled registration fee, the honest answer is that no such line exists in the published schedule.

Insight two: Article 26 places the power to revise fees in an executive decree, which means the amounts will change. The second sentence of Article 26 of Ley 90 reads: Las tarifas serán establecidas por la autoridad de salud y la Dirección Nacional de Dispositivos Médicos y actualizadas mediante decreto ejecutivo. The prices in Article 64 are at their 2019 level, and whether they have since been adjusted by a later decree has to be checked against the most recent instruments (practical estimate). Any quotation that presents the B/. figures as current without a search of subsequent decrees is quoting an assumption rather than a verified position.

Insight three: the CCT is free, but per-category procedures introduced since 2019 are charged. The free-of-charge principle in the third paragraph of Article 21 does not conflict with the B/.300.00 in Resolución N° 003, because the first concerns the CCT while the second concerns a registration (inscripción). The two instruments address different procedures, and the pattern is informative: as Panama rebuilds product access, the newly created procedures carry fees, while the older certificate remains free. For budgeting purposes this means the product side is not necessarily zero cost simply because the CCT is.

Insight four: the manner of payment is written into the provisions, which makes it a formal requirement. Article 64 requires that fees be paid at the Dirección Nacional de Dispositivos Médicos with the presentation of the respective application (deberán pagarse en la Dirección Nacional de Dispositivos Médicos, con la presentación de la solicitud respectiva), while Resolución N° 003 directs payment to the finance department of the Ministry of Health. The two procedures therefore have different payees and produce different proof of payment, and that proof is itself a documentary requirement: item 7 of Article 17 asks for the comprobante de pago. A receipt from the wrong office is a defective filing, not a minor irregularity.

4. Practical recommendations

  • Show official fees in quotations item by item against Article 64, separately from third-party costs such as translation, notarisation and consultancy.
  • State that official fees are those published at the time of filing, given the updating mechanism in Article 26.
  • Exclude the CCT from the fee calculation but include ISO 13485, certification, translation and representative costs in the overall budget.
  • Confirm the fee and the payee separately for each per-category procedure, noting that Resolución 003 directs payment to the Ministry of Health finance department.
  • Obtain the proof of payment in the format the receiving office requires and file it as part of the application.
  • Check for any later executive decree adjusting the schedule before presenting figures to a client.

5. Verification checklist

  • □ Licence fees checked against Article 64 (B/.150 to B/.350)
  • □ Licence update fee of B/.25.00 recorded
  • □ CCT confirmed as free of charge (Article 21, third paragraph)
  • □ Per-category procedure fee and payee confirmed (Resolución 003: B/.300.00)
  • □ Any executive decree updating fees searched (Article 26)
  • □ Proof of payment obtained in the form required by the receiving office

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Panamanian market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail